UrgentRx Garners $2,500,000 Series B Round

  • Feed Type
  • Date
    4/3/2013
  • Company Name
    UrgentRx
  • Mailing Address
    1610 Wynkoop St Denver, CO 80202
  • Company Description
    UrgentRx is a line of fast-acting, portable OTC medications providing right now relief for today’s busy, “on-the-go” consumer. UrgentRx Fast Powders come in an innovative, fast-acting flavored powder format available in convenient, single-dose, credit-card-sized packets for easier portability and accessibility.
  • Website
    http://www.urgentrx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,500,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    This additional funding will allow UrgentRx to accelerate efforts to reach consumers and support our retail partners as we expand into more and more markets.
  • M&A Terms
  • Venture Investor
    JUMP Investors
  • Venture Investor
    Investor
  • Venture Investor
    Investor
  • Venture Investor
    Investor
  • Venture Investor
    Investor
  • Venture Investor
    Boulevard Capital Partners

By posting a comment, you agree to our terms and conditions.